Bridgebio Pharma Inc. (bbio 2.5 03/15/27)
13F holders, Q4 2024 (December 31)5holders +2
2new positions
0sold out
$1.05avg. 13F price*
At the end of Q4 2024, 5 institutions reported holding Bridgebio Pharma Inc. (bbio 2.5 03/15/27) in their 13F filings, up 2 from Q3 2024. 2 opened new positions and 0 sold out. The largest holders were New York State Common Retirement Fund ($5.4M), Toronto Dominion Bank ($522K) and Bank of New York Mellon Corp ($315K).
- Company
- Bridgebio Pharma Inc. (bbio 2.5 03/15/27)
- CUSIP
- 10806XAB8
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $523K |
| Exits | 0 | $0 |
All 13F filers, Q3 2024 → Q4 2024: 812,000 shares bought and 200,000 shares sold, net +612,000 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 5 holders
| New York State Common Retirement Fund | 0.01% | Add +6.3% | 5,131,000 | $5.4M |
| Toronto Dominion Bank | 0.00% | New | 500,000 | $522K |
| Bank of New York Mellon Corp | 0.00% | Reduce -40.0% | 300,000 | $315K |
| Choreo, LLC | 0.00% | Add +20.7% | 35,000 | $37K |
| Jones Financial Companies LLLP | 0.00% | New | 1,000 | $1K |
"% of holder's portfolio" is BRIDGEBIO PHARMA INC (BBIO 2.5 03/15/27)'s weight in each manager's 13F, not the share of Bridgebio Pharma Inc. (bbio 2.5 03/15/27) the manager owns.